Differences

This shows you the differences between two versions of the page.

--- home:special:surgery [01.12.2019] – [Marshall Protocol medications and general anesthesia] sallieq
+++ home:special:surgery [09.14.2022] (current) – external edit 127.0.0.1
@@ Line 12: / Line 12: @@
 Continuing MP medications along with most other antibiotics administered in conjunction with surgery may result in a strong immune system reaction. MP patients may not want to combine the suffering after a procedure with immunopathology.
-It is preferable to consult with hospital staff and negotiate use of compatible ABx if at all possible in order to improve surgical outcome. [[http://anesthesiology.pubs.asahq.org/Article.aspx?articleid=2318959|Continuing Olmesartan reduces surgical risk]]
+It is preferable to consult with hospital staff and negotiate use of compatible ABx if at all possible in order to improve surgical outcome. [[https://anesthesiology.pubs.asahq.org/Article.aspx?articleid=2318959|Continuing Olmesartan reduces surgical risk]]
+So if a patient must take an antibiotic, Ceftin, Biaxin or fluoroquinolones are recommended, as they minimize the possibility of unstable immunopathology. Use of these does not preclude an MP patient from continuing with olmesartan.
 MP patients who do not discontinue MP medications before surgery should use their knowledge of what adjustment of MP medications works for them to dampen immune system reactions prior to, and during recovery from the procedure.
@@ Line 48: / Line 50: @@
 {{tag>surgery specialists Special_issues special }}
+<nodisp>
 ===== Notes and comments =====
   * Legacy content
-    * http://www.marshallprotocol.com/forum32/1125.html#p8885 f176
+    * https://www.marshallprotocol.com/forum32/1125.html#p8885 f176
     *
     *
   *
-===== References =====
+===== References =====</nodisp>

home/special/surgery.txt · Last modified: 09.14.2022 by 127.0.0.1